
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has demonstrated strong financial performance, achieving record revenue of $1.7 billion, which reflects a 10% increase year-over-year, supported by significant growth in both Clearing & Transaction and Market Data revenue. The company also experienced robust international expansion, with record quarterly volume driven by EMEA (15% increase year-over-year) and APAC (30% increase year-over-year), indicating a broadening market reach. Additionally, CME Group successfully attracted over 90,000 new retail traders, marking a 56% year-over-year growth and representing the fifth consecutive quarter of double-digit growth in this segment.
Bears say
CME Group faces significant risks that could negatively impact its stock performance, primarily due to the potential decline in open interest (OI), which may lead to deteriorating sentiment and financial conditions. Moreover, regulatory risks such as increased margin requirements and limitations on trading practices can reduce trading volumes, while the company's heavy reliance on market volatility exacerbates its vulnerability to low volatility conditions. Additionally, changes in industry fundamentals, competitive dynamics, or unforeseen management issues may adversely affect expected revenues, earnings, and overall investor confidence in CME Group.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares